Retatrutide's TRIUMPH-2 Data Prompts Reevaluation of Metabolic Trial Designs | Retatrutide News

Retatrutide's TRIUMPH-2 trial data is causing a reevaluation of metabolic trial designs. This could impact future clinical methodologies for GLP-1 agoni...
Clinical Trials · October 22, 2026